Phase I/II Ex Vivo Gene Therapy Clinical Trial for Recessive Dystrophic Epidermolysis Bullosa Using Skin Equivalent Grafts Genetically Corrected with a COL7A1-Encoding SIN Retroviral Vector (GENEGRAFT)

HUMAN GENE THERAPY CLINICAL DEVELOPMENT

Volume 25, Issue 2, Pages 65-66

MARY ANN LIEBERT, INC

-

Biotechnology & Applied Microbiology Critical Care Medicine Medicine, Research & Experimental